Literature DB >> 7011445

Malaria-induced thrombocytopenia.

R D Horstmann, M Dietrich, U Bienzle, H Rasche.   

Abstract

Platelet counts were investigated in 26 patients with P. falciparum malaria and 39 patients with P. vivax malaria before and after treatment. Before schizontocidal treatment 22 of 26 (85%) patients with P. falciparum malaria and 30 of 39 (72%) patients with P. vivax malaria had depressed platelet counts below 150,000/microliters blood. There was a correlation between low platelet counts and high counts of malarial plasmodia (parasitized red blood cells) in P. falciparum and P. vivax infections (p less than 0.001). Platelet survival, studied by malonaldehyde formation in three patients during the period of decreasing parasitaemia, revealed a shortened life span to 2--3 days in comparison to 7--10 days in normal controls. In all patients platelet counts rose to threefold the initial values within 5 days after clearance of parasites. The results demonstrate that, first, thrombocytopenia is a common feature in human malaria, second, thrombocytopenia induced by malaria is due to shortened life span in the peripheral blood and, third, some interaction is present between platelets and malaria plasmodia or parasitized red cells.

Entities:  

Mesh:

Year:  1981        PMID: 7011445     DOI: 10.1007/bf01026385

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  10 in total

1.  A simple nonradioisotope technic for the determination of platelet life-span.

Authors:  M J Stuart; S Murphy; F A Oski
Journal:  N Engl J Med       Date:  1975-06-19       Impact factor: 91.245

2.  THROMBOCYTOPENIA IN VIVAX MALARIA.

Authors:  G J HILL; V KNIGHT; G M JEFFERY
Journal:  Lancet       Date:  1964-02-01       Impact factor: 79.321

3.  Studies on fibrinolytic activity in patients with Plasmodium falcipalum malaria.

Authors:  S Areekul; K Devakul; P Vivatanasesth; K Kanakakorn; R Kasemsuth
Journal:  Southeast Asian J Trop Med Public Health       Date:  1972-06       Impact factor: 0.267

4.  Blood coagulation studies in Plasmodium falciparum malaria.

Authors:  T Butler; M J Tong; J R Fletcher; R J Dostalek; T O Robbins
Journal:  Am J Med Sci       Date:  1973-01       Impact factor: 2.378

5.  Fibrin-degradation products in cerebral malaria.

Authors:  H A Reid; F K Nkrumah
Journal:  Lancet       Date:  1972-01-29       Impact factor: 79.321

6.  Disseminated intravascular coagulation with fatal haemorrhage in cerebral malaria.

Authors:  D Borochovitz; A L Crosley; J Metz
Journal:  Br Med J       Date:  1970-06-20

7.  Depletion of coagulation factors in drug-resistant Plasmodium falciparum malaria.

Authors:  L H Dennis; J W Eichelberger; M M Inman; M E Conrad
Journal:  Blood       Date:  1967-05       Impact factor: 22.113

8.  Haemostatic defect in non-immune patients with falciparum malaria: no evidence of diffuse intravascular coagulation.

Authors:  J Vreeken; T M Cremer-Goote
Journal:  Br Med J       Date:  1978-08-19

9.  Mechanisms of thrombocytopenia in malignant tertian malaria.

Authors:  R B Skudowitz; J Katz; A Lurie; J Levin; J Metz
Journal:  Br Med J       Date:  1973-06-02

10.  Thrombocytopenia in malaria with immunoglobulin (IgM) changes.

Authors:  P J Beale; J D Cormack; T B Oldrey
Journal:  Br Med J       Date:  1972-02-05
  10 in total
  21 in total

1.  T-cell-dependent immunity and thrombocytopenia in rats infected with Plasmodium chabaudi.

Authors:  H Watier; C Verwaerde; I Landau; E Werner; J Fontaine; A Capron; C Auriault
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

2.  Successful treatment of malaria tropica with acute renal failure and cerebral involvement by plasmapheresis and hemodialysis.

Authors:  U Stuby; W Kaiser; G Biesenbach; J Zazgornik
Journal:  Infection       Date:  1988       Impact factor: 3.553

3.  A case of symptomatic splenic infarction in vivax malaria.

Authors:  Areum Kim; Yun-Kyu Park; Jin-Soo Lee; Moon-Hyun Chung; Eun Sil Kim
Journal:  Korean J Parasitol       Date:  2007-03       Impact factor: 1.341

4.  Immunopathology of thrombocytopenia in experimental malaria.

Authors:  G E Grau; P F Piguet; D Gretener; C Vesin; P H Lambert
Journal:  Immunology       Date:  1988-12       Impact factor: 7.397

5.  Comparison of the Clinical Profile and Complications of Mixed Malarial Infections of Plasmodium Falciparum and Plasmodium Vivax versus Plasmodium Falciparum Mono-infection.

Authors:  Vivek Joseph; Muralidhar Varma; Sudha Vidhyasagar; Alvin Mathew
Journal:  Sultan Qaboos Univ Med J       Date:  2011-08-15

6.  [Malaria tropica with activation of blood coagulation and detection of tumor necrosis factor (NF-alpha) in serum].

Authors:  C J Hemmer; P Kern; K P Radtke; R E Egbring; P P Nawroth; M Dietrich
Journal:  Klin Wochenschr       Date:  1990-03-05

7.  Rapid diagnosis of vivax malaria by the SD Bioline Malaria Antigen test when thrombocytopenia is present.

Authors:  Sei Won Lee; Kyeongman Jeon; Byung Ryul Jeon; Inho Park
Journal:  J Clin Microbiol       Date:  2007-12-26       Impact factor: 5.948

8.  Inhibition of platelet adherence to brain microvasculature protects against severe Plasmodium berghei malaria.

Authors:  Guang Sun; Wun-Ling Chang; Jie Li; Seth Mark Berney; Donald Kimpel; Henri C van der Heyde
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

9.  Immune-mediated thrombocytopenia of malaria.

Authors:  J G Kelton; J Keystone; J Moore; G Denomme; E Tozman; M Glynn; P B Neame; J Gauldie; J Jensen
Journal:  J Clin Invest       Date:  1983-04       Impact factor: 14.808

Review 10.  Blood coagulation, inflammation, and malaria.

Authors:  Ivo M B Francischetti; Karl B Seydel; Robson Q Monteiro
Journal:  Microcirculation       Date:  2008-02       Impact factor: 2.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.